PharmTech Drug Digest 11.20
News|Articles|June 8, 2015

Application Optimized Microplate Products from Porvair Sciences

Porvair has developed a 2-ml 96 round-well deep-well plate that enables scientists to use the full 2.00 ml well capacity.

Visitors can view a range of application optimized microplates and microplate equipment at Porvair Sciences’ stand. For laboratories involved with fraction collecting, compound storage, plate replication, and mixing applications, Porvair has developed a 2-ml 96 round-well deep-well plate that enables scientists to use the full 2.00 ml well capacity. Manufactured under class 10,000 conditions from ultra-pure grade polypropylene these plates are certified as RNase/DNase free and contain no measurable contaminants that could otherwise leach out and affect the sample, according to Porvair. 



Also on display is the Ultravap Levante, which is the latest edition in Porvair’s series of nitrogen blow-down sample concentrators and evaporators. Using technology from the Ultravap Mistral series of robot-ready, integration-compatible evaporators, Porvair has re-designed the classic single plate evaporator to meet the needs of the modern laboratory. The Ultravap Levante and Ultravap Mistral make it easier to integrate an automatic dry down step into an automated liquid handling protocol.

In addition, Porvair is exhibiting its extensive range of reagent reservoirs and deep well, shallow well, storage, assay, SPE, protein precipitation and filtration microplates precisely manufactured to comply with ANSI/SLAS dimensions. 



Source: Porvair Sciences, Hall 4.2, Stand F44


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.